Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irene Caramella
Observed names:
I Caramella,
I. Caramella,
I., Caramella,
IRENE CARAMELLA,
Irene CARAMELLA
Institutions:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,
Fondazione Poliambulanza Istituto Ospedaliero,
University of Brescia
Observed institutions:
University of Milan,
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,
Fondazione Poliambulanza Istituto Ospedaliero,
European Institute of Oncology,
University of Brescia
ORCID:
0000-0001-7422-0119
Observed ORCID:
0000-0001-7422-0119
OpenAlex ID:
A5015040760
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients
2023
·
Alberto Dalla Volta
, Irene Caramella
, et al.
·
Current Oncology Reports
·
18
PDF
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health—the BLADE study
2023
·
A. Dalla Volta
, C. Palumbo
, et al.
·
Journal of Endocrinological Investigation
·
13
PDF
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation
2022
·
Marco Bergamini
, Alberto Dalla Volta
, et al.
·
Frontiers in Oncology
·
12
PDF
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study
2024
·
M Bergamini
, A Dalla Volta
, et al.
·
eLife
·
8
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study
2025
·
Martina Buffoni
, Alberto Dalla Volta
, et al.
·
European Urology Oncology
·
7
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials
2024
·
Eleonora Nicolò
, Sara Gandini
, et al.
·
European Journal of Cancer
·
7
Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib
2023
·
ALBERTO DALLA VOLTA
, ANDREA DELBARBA
, et al.
·
In Vivo
·
5
PDF
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients?
2021
·
Irene Caramella
, Alberto Dalla Volta
, et al.
·
Prostate Cancer and Prostatic Diseases
·
3
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study)
2026
·
I. Caramella
, A. Dalla Volta
, et al.
·
Bone
·
2
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis
2024
·
Marco Bergamini
, Alberto Dalla Volta
, et al.
·
Case Reports in Oncology
·
2
PDF
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
2022
·
Irene Caramella
, Alberto Dalla Volta
, et al.
·
Endocrine
·
2
PDF
Decoding Microbiota in Genitourinary Oncology: Biological Mechanisms and Clinical Implications—A Narrative Review
2026
·
Irene Caramella
, Chiara Abeni
, et al.
·
Cancers
·
1
PDF
Author response: Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study
2024
·
Marco Bergamini
, Alberto Dalla Volta
, et al.
·
eLife
·
1
Cancer-Related Cognitive Impairment in Breast Cancer: Current State of Knowledge, Mechanisms, Diagnosis, Prevention and Treatment
2026
·
Federica Andreis
, Chiara Deori
, et al.
·
Cancers
PDF
P141 Multiparametric assessment of bone response in metastatic castration resistant prostate cancer patients treated with cabozantinib upon progression to chemotherapy and androgen receptor pathway inhibitors: A phase II study (MERIDIAN)
2024
·
A. Dalla Volta
, S. Trapattoni
, et al.
·
European Urology Open Science
Supplementary Material for: PATHOLOGICAL COMPLETE RESPONSE TO PEMBROLIZUMAB PLUS AXITINIB COMBINATION FOLLOWING SERIOUS IMMUNE-RELATED ADVERSE EVENTS IN AN ADVANCED RENAL CELL CARCINOMA PATIENT WITH A HISTORY OF RHEUMATOID ARTHRITIS
2024
·
M., Bergamini
, A., DallaVolta
, et al.
·
Figshare
1785P Changes in bone mineral density, trabecular bone score and body composition in metastatic hormone-sensitive prostate cancer (mHSPC) patients randomized to receive androgen deprivation + enzalutamide plus/minus zoledronic acid: The BonEnza study
2023
·
A. Dalla Volta
, F. Valcamonico
, et al.
·
Annals of Oncology
PDF
Is adjuvant immunotherapy effective in patients with urothelial cancer?
2022
·
Alberto DALLA VOLTA
, Fausto PETRELLI
, et al.
·
Minerva Urology and Nephrology
Clinical benefit and response rate in early phase clinical trials: First report from a single-institution study
2019
·
A. Marra
, E. Ferraro
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
19
Citation count:
81
H-index:
6
I10-index:
3
Year
Topic
Type